public hearing
NPA Issues Statement in Response to FDA’s Refusal to Hold Public Hearing Regarding NMN
On July 20, the U.S. Food and Drug Administration (FDA) rejected a request by Rep. Jeff Duncan (R-SC), a member of the House Energy and Commerce Committee, to hold a public hearing on the agency’s position on nicotinamide mononucleotide (NMN). FDA stated that a public comment period would be sufficient. In response, the Natural Products ...
NPA Files Citizen Petition with FDA
In a Citizen’s Petition to the U.S. Food and Drug Administration (NPA), the Natural Products Association (NPA) requested that N-acetyl-L-cysteine (“NAC”) not be excluded from the definition of a dietary supplement. “The Food and Drug Administration has not established a public health risk for NAC,” said Daniel Fabricant, PhD, president and CEO of NPA. “Not ...
Don't Miss Out!
Industry Professionals
Stay Informed!
Stay informed about the latest health, nutrition, and wellness developments by signing up for a FREE subscription to Nutrition Industry Executive magazine and digital newsletter.
Once subscribed, you will receive industry insights, product trends, and important news directly to your doorstep and inbox.


